Abstract
Surgery for proliferative vitreoretinopathy (PVR) may require prolonged procedures often with limited improvement in visual function. Forty-seven consecutive patients who had PVR surgery in one eye had a case note review to assess anatomical re-attachment rate and improvement in visual acuity. All patients had at least 3 clock-hours of grade C PVR membrane. Surgery comprised vitrectomy and membrane peel in all cases. There was a mean follow-up period of 9 months (range 3–23 months). Thirty-two eyes (68%) had an attached retina with the mean visual acuity being 0.089 (where 6/60 = 0.10). A mean of 2.15 PVR operations were performed per eye. Seventeen patients chosen at random were contacted by telephone and standardised questions were asked regarding their surgery. Eleven (65%) patients stated that, with the benefit of hindsight, they would still have had surgery and 8 (47%) patients stated that the peripheral vision gained was of benefit.
Similar content being viewed by others
Article PDF
References
The Retinal Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:121–5.
Rachal WF, Burton TC . Changing concepts of failures after retinal re-attachment surgery. Arch Ophthalmol 1979:97:480–3.
Bonnet M . Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment. Ophthalmologica 1984;188:148–52.
Cowley M . Conway BP, Campochiaro P, Kaiser PH, Gaskin H . Clinical risk factors for proliferative vitreoretinopathy. Arch Ophlhalmol 1989;107:1147–51.
Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM . An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991;112:159–65.
Lean JS, Stern WA, Irvine AR, Azen SP and the Silicone Study Group. Classification of proliferative vitreoretinopathy used in the silicone study. Ophthalmology 1989;96:765.
Wiedemann P, Leinung C, Hilgers RD, Heimann K . Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1991;229:150–2.
Wiedemann P, Heimann K . Toxicity of intraocular dauno-mycin. Lens Eye Toxic Res 1990;7:305–10.
Hopkins A . Measuring the quality of medical care. London: Royal College of Physicians, 1992:55–9.
Sullivan PM, Luff AJ, Julious SA, Canning CR . Patient satisfaction following vitreoretinal surgery. Eye 1993;7:433–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCormack, P., Simcock, P., Charteris, D. et al. Is surgery for proliferative vitreoretinopathy justifiable?. Eye 8, 75–76 (1994). https://doi.org/10.1038/eye.1994.14
Issue Date:
DOI: https://doi.org/10.1038/eye.1994.14